Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
this need by designing a multimeric antibody construct able to inhibit neutrophil elastase, the main protease involved in lung damages, to localize specifically to the inflamed lung parenchyma and thereby
-
proteins suitable for therapeutical targeting by bi or tri-specific T-cell engager antibody and/or radionuclide-conjugated antibody. This translational project aims to identify targets of interest
-
Biologics Screening Core within the Department of Host Microbe Interactions at St. Jude seeks a skilled and highly motivated candidate with experience in Antibody Discovery . This is a unique opportunity to
-
Scheduled Hours 40 Position Summary Immediate opening for a scientist experienced in antibody development, immunization models and core laboratory operation to join current team. Position will
-
are not curative. To enhance their efficacy, BTK/PI3K inhibitors are commonly combined with anti-CD20 monoclonal antibodies. We suppose that BTK inhibitors (BTKi) disrupt the regulation of CD20
-
University of California San Francisco | San Francisco, California | United States | about 12 hours ago
monitoring the antibody, reagent, and control material logs to be sure that they are accurate and current. Performs the full scope of technical duties in the laboratory as needed. Under guidance and
-
: 87384BR This is a training position. The Trainee will be enrolled in a state-approved training program for the Clinical Histocompatibility Scientist (CHS). (https://www.cdph.ca.gov/Programs/OSPHLD/LFS/Pages
-
fusion mechanisms mediated by respiroviruses and strategies to prevent infection. Candidate will apply techniques including antibody assessment, virus neutralization assays, and molecular biology and
-
, neoantigens, cytokines, and antibodies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Bristol Myers Squibb, Duality
-
at matralis-lab , to generate novel compounds (small molecules, proteins, antibody-drug conjugates) that target novel molecular pathways with key roles in cancer progression. (S)he will also work towards